Opsonization of T1M1 group A Streptococcus:: Dynamics of antibody production and strain specificity

被引:14
作者
Eriksson, BKG
Villasenor-Sierra, A
Norgren, M
Stevens, DL
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Infect Dis, Dept Med, S-14186 Huddinge, Sweden
[2] Umea Univ, Dept Clin Bacteriol, Umea, Sweden
[3] Occidente Inst Mexicano Seguro Social, Ctr Invest Biomed, Guadalajara, Jalisco, Mexico
[4] Vet Affairs Med Ctr, Boise, ID USA
[5] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
10.1086/318448
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A chemiluminescence method was used to study opsonization of group A Streptococcus (GAS) of serotype T1M1 in serum samples ("sera") obtained from Swedish patients with invasive and noninvasive GAS infection and from healthy blood donors. Acute-phase serum samples ("acute sera") generally demonstrated low ability to opsonize the patient's own GAS isolate, regardless of clinical manifestation. Only similar to 15% of serum samples obtained from healthy blood donors demonstrated high opsonic activity against a standard T1M1 strain. Opsonization of 62 T1M1 isolates (obtained during 1980-1998) by a single immune serum sample showed considerable variation; this indicates that high opsonic immunity may develop only against the infecting isolate or identical clones. T1M1 GAS isolated from 1987 through 1990 were better opsonized by the immune serum sample than were isolates obtained before 1987 or after 1990, a finding that suggests a temporal change of the surface properties that affect opsonization.
引用
收藏
页码:E24 / E30
页数:7
相关论文
共 31 条
  • [1] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION
    BREIMAN, RF
    DAVIS, JP
    FACKLAM, RR
    GRAY, BM
    HOGE, CW
    KAPLAN, EL
    MORTIMER, EA
    SCHLIEVERT, PM
    SCHWARTZ, B
    STEVENS, DL
    TODD, JK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03): : 390 - 391
  • [2] Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease
    Cockerill, FR
    Thompson, RL
    Musser, JM
    Schlievert, PM
    Talbot, J
    Holley, KE
    Harmsen, WS
    Ilstrup, DM
    Kohner, PC
    Kim, MH
    Frankfort, B
    Manahan, JM
    Steckelberg, JM
    Roberson, F
    Wilson, WR
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1448 - 1458
  • [3] An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children
    Cockerill, FR
    MacDonald, KL
    Thompson, RL
    Roberson, F
    Kohner, PC
    BesserWiek, J
    Manahan, JM
    Musser, JM
    Schlievert, PM
    Talbot, J
    Frankfort, B
    Steckelberg, JM
    Wilson, WR
    Osterholm, MT
    Abbott, JA
    Badley, AD
    Dale, JC
    Dylla, BL
    Holley, KE
    Jacobsen, RA
    Leavelle, DE
    Osmon, DR
    Uhl, JR
    Vetter, EA
    Anderson, EA
    Clare, JG
    Forfang, JC
    Hedberg, CW
    Korlath, JA
    Rainbow, JI
    Edmonson, L
    Lovgren, M
    Olstad, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (01): : 38 - 43
  • [4] New protective antigen of group A streptococci
    Dale, JB
    Chiang, EY
    Liu, SY
    Courtney, HS
    Hasty, DL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) : 1261 - 1268
  • [5] Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci
    Dale, JB
    Washburn, RG
    Marques, MB
    Wessels, MR
    [J]. INFECTION AND IMMUNITY, 1996, 64 (05) : 1495 - 1501
  • [6] PROTECTIVE IMMUNITY TO THE GROUP-A STREPTOCOCCUS MAY BE ONLY STRAIN-SPECIFIC
    DEMALMANCHE, SA
    MARTIN, DR
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1994, 183 (06) : 299 - 306
  • [7] TYPE-SPECIFIC STREPTOCOCCAL ANTIBODY
    DENNY, FW
    PERRY, WD
    WANNAMAKER, LW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (07) : 1092 - 1100
  • [8] Erysipelas: Clinical and bacteriologic spectrum and serological aspects
    Eriksson, B
    JorupRonstrom, C
    Karkkonen, K
    Sjoblom, AC
    Holm, SE
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) : 1091 - 1098
  • [9] Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome
    Eriksson, BKG
    Andersson, J
    Holm, SE
    Norgren, M
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) : 1428 - 1436
  • [10] Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome
    Eriksson, BKG
    Andersson, J
    Holm, SE
    Norgren, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 410 - 418